CONMED Corporation CNMD
NYSE
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 1.62% | 3.42% | 4.14% | 5.18% | 4.61% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.62% | 3.42% | 4.14% | 5.18% | 4.61% |
| Cost of Revenue | 2.84% | 4.91% | 8.53% | 9.93% | 4.88% |
| Gross Profit | 0.65% | 2.27% | 0.74% | 1.47% | 4.40% |
| SG&A Expenses | -1.10% | 0.28% | 0.45% | 5.54% | 5.65% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.60% | 3.14% | 4.90% | 7.60% | 4.89% |
| Operating Income | 1.78% | 5.59% | -1.60% | -12.23% | 2.44% |
| Income Before Tax | 22.76% | -39.55% | -43.70% | -56.38% | -46.58% |
| Income Tax Expenses | 47.10% | -2.77% | 1.59% | -21.38% | -24.34% |
| Earnings from Continuing Operations | 14.61% | -48.73% | -53.81% | -64.47% | -51.37% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 14.61% | -48.73% | -53.81% | -64.47% | -51.37% |
| EBIT | 1.78% | 5.59% | -1.60% | -12.23% | 2.44% |
| EBITDA | 2.40% | 5.03% | 0.25% | -7.34% | 2.52% |
| EPS Basic | 16.92% | -48.06% | -53.80% | -64.59% | -51.56% |
| Normalized Basic EPS | 5.88% | 14.53% | 2.53% | -11.81% | 7.23% |
| EPS Diluted | 17.92% | -47.66% | -53.41% | -64.38% | -51.31% |
| Normalized Diluted EPS | 6.15% | 15.03% | 3.08% | -11.27% | 8.26% |
| Average Basic Shares Outstanding | -1.82% | -0.91% | -0.08% | 0.38% | 0.48% |
| Average Diluted Shares Outstanding | -2.02% | -1.32% | -0.61% | -0.28% | -0.47% |
| Dividend Per Share | -100.00% | -75.00% | -50.00% | -25.00% | 0.00% |
| Payout Ratio | -0.78% | -0.02% | 0.63% | 1.83% | 1.07% |